<SUBMISSION>
<ACCESSION-NUMBER>0001193125-06-253446
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20061212
<ITEMS>8.01
<ITEMS>9.01
<FILING-DATE>20061214
<DATE-OF-FILING-DATE-CHANGE>20061214
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AtriCure, Inc.
<CIK>0001323885
<ASSIGNED-SIC>3841
<IRS-NUMBER>341940305
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-51470
<FILM-NUMBER>061277714
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>6033 SCHUMACHER PARK DRIVE
<CITY>WEST CHESTER
<STATE>OH
<ZIP>45069
<PHONE>513-755-4107
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>6033 SCHUMACHER PARK DRIVE
<CITY>WEST CHESTER
<STATE>OH
<ZIP>45069
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML><HEAD>
<TITLE>Current Report</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:3px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="3"><B>PURSUANT TO SECTION 13 OR 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>SECURITIES EXCHANGE ACT OF 1934 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Date of Report (Date of earliest event reported): December&nbsp;12, 2006 </B></FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>AtriCure, Inc. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of registrant as specified in charter) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR
WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>000-51470</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>34-1940305</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>6033 Schumacher Park Drive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>West Chester, OH</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>45069</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code: (513)&nbsp;755-4100 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Not Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or
former address, if changed since last report) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;8.01. Other Events. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2">We announced today that we and certain of our officers have been named as defendants in purported securities class action lawsuits filed in the United States District Court for the Southern District of New York. The
suits allege violations of the federal securities laws and seek damages on behalf of purchasers of our common stock during the period from our Initial Public Offering in August 2005 through February&nbsp;16, 2006. We believe that these allegations
are without merit and we intend to vigorously defend against them. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">We do not intend to file further Current Reports on Form 8-K describing
any additional lawsuits that may be filed that are based on allegations substantially similar to those described above. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">A copy of the
press release announcing the filing of the lawsuit is attached as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference in its entirety. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2"><B>Item&nbsp;9.01. Financial Statements and Exhibits. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(d) Exhibits. </FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="95%"></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-right:0px;margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="1"><B>No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of AtriCure, Inc. dated as of December 14, 2006.</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2">ATRICURE, INC.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1px;border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="2">/s/ David J. Drachman</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">David J. Drachman</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Dated: December&nbsp;14, 2006 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>EXHIBIT LIST </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="95%"></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-right:0px;margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="1"><B>No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of AtriCure, Inc. dated as of December 14, 2006.</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px">

<IMG SRC="g14801img001.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Contacts: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><I>AtriCure, Inc.</I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">David J.
Drachman</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(513)
755-5758</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">ddrachman@atricure.com</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><I>The Ruth Group</I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Nick Laudico
(investors)</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(646) 536-7030</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">nlaudico@theruthgroup.com</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Jason Rando (media)</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">(646) 536-7025</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">jrando@theruthgroup.com</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Press Release </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>AtriCure Responds to Securities Class Action Lawsuit </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">WEST CHESTER, Ohio &#150; December&nbsp;14, 2006 &#150;
AtriCure, Inc. (Nasdaq:ATRC), a medical device company focused on developing, manufacturing and selling innovative surgical devices, announced today that it and certain of its officers have been named as defendants in purported securities class
action lawsuits filed in the United States District Court for the Southern District of New York. The suits allege violations of the federal securities laws and seek damages on behalf of purchasers of the Company&#146;s common stock during the period
from its Initial Public Offering in August 2005 through February&nbsp;16, 2006. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">David Drachman, President and Chief Executive Officer said, &#147;We
believe that these allegations are without merit and we intend to vigorously defend the Company. As a public company, the Company has maintained insurance coverage to address such matters. Management is and will remain focused on the growth and
development of our Company.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">About AtriCure, Inc. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft and cardiac tissues. Medical journals have described the adoption by
leading cardiothoracic surgeons of the AtriCure bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal
electrical impulses that cause atrial fibrillation, a rapid, irregular quivering of the upper chambers of the heart. Atrial fibrillation affects more than 2.4&nbsp;million people in the U.S. and predisposes them to a five fold increased risk of
stroke. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">The FDA has cleared the AtriCure bipolar ablation system for the ablation, or destruction, of soft tissues in general and
non-cardiac related surgical procedures but to date has not cleared or approved the system for cardiac use or for the treatment of AF. The FDA has cleared the AtriCure Isolator</FONT><FONT FACE="Times New Roman" SIZE="1"
COLOR="#000000"><SUP>(TM)</SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> Transpolar</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP>(TM)</SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> Pen for
the ablation of cardiac tissue and the evaluation of cardiac arrhythmias, but the Isolator</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP>(TM)</SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">
Transpolar</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP>(TM)</SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> Pen has not been approved for the treatment of AF. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">This press release contains &#147;forward-looking statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements
include statements that address activities, events or developments that AtriCure expects, believes or anticipates will or may occur in the future, such as earnings estimates, other predictions of financial performance, launches by AtriCure of new
products and market acceptance of AtriCure&#146;s products. Forward-looking statements are based on AtriCure&#146;s experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate
under the circumstances and are subject to numerous risks and uncertainties, many of which are beyond AtriCure&#146;s control. These risks and uncertainties include the rate and degree of market acceptance of AtriCure&#146;s products,
AtriCure&#146;s ability to develop and market new and enhanced products, the timing of and ability to obtain and maintain regulatory clearances and approvals for its products, the timing of and ability to obtain reimbursement of procedures utilizing
AtriCure&#146;s products, competition from existing and new products and procedures or AtriCure&#146;s ability to effectively react to other risks and uncertainties described from time to time in AtriCure&#146;s SEC filings, such as fluctuation of
quarterly financial results, reliance on third party manufacturers and suppliers, litigation (including the purported class action lawsuit) or other proceedings, government regulation and stock price volatility. AtriCure does not guarantee any
forward-looking statement, and actual results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward- looking statement, whether as a result of new information, future events or otherwise.
</FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g14801img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14801img001.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`40$'`P$1``(1`0,1`?_$`-8``0`"`@,!`0$!````
M```````)"@<(`04&!`(#"P$!``$$`P$```````````````,!`@<(!08)!!``
M``4#`P,!!`0'"P<-`0```0(#!`4`!@<1$@@A$PDQ02(4%5%A<3(C=;46&#@*
M\(&1H=%BLB4V=A="4G(D1C<HP<(STU3$1=5F9Y>G2#D1``$#`@4"`P4"!PP%
M#0````$``@,1!"$2!08',4%1$PAA<2(R%8$4H<%"4G*R%F*"DM(C,W24-1<W
M&)'14W.T\+%C@Y.SPS14155U)__:``P#`0`"$0,1`#\`O\41*(E$6M/)[D0S
MX[V7'SI(E&X;AG94D9!P:[P6**Q4R"O(/G*Y$UEB-6:0%*.PAC"HJ0---1"Y
MK<QIV5":!=SQRSM&\@,?)W>VCPAI1F^6B;@A0<`[+'R*)2JE!%QM(=5LY;*$
M43$Q2FVFZ@`T<W*:=D!JL^U:JI1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(
ME$2B)1$HB41*(E$2B)1$HB41*(E$2B*!7R`9-&]\V'MAFMW8C',>6$(4A^XF
M:9>]M],N$^GNG+O1;G#V&;C4[!1JC<:E>F\=&3@M?*DICYZN*<9D"-[C$BIQ
M!,EP0I%%T2I$Z`*SY@=0HC[01"D@J*CLJMZJ<2H%>E$2B)1$HB41*(E$2B)1
M$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41>*R/>+''UAW9>DB<
M"-;;@9*5,&XI3*J-6RAT$$]P^\JNL!2E`.HF'0*J!4T0X*OU@'&3ODSG)2-N
M-V]3:2QYV\;SE6(D!VF@=0RJAD3N"J)E.ZEWJ*?4#"!5!$-=.GT.(:%$,2O*
M7E`S?'/.KV/:K.OC<=W:W?Q+PX`FO(Q2*Q'3)P.WH4)2,.)1T#H50:J!5M4Z
M&BL@6=<\=>=JV]=<4LFM'W#$LI5LHD;<F)72)%#D*;V]I01*/UA7S$4-"I1B
MO2U1$HB41*(E$2B)1%Y>]+QM_']KS-XW2^+'0$"S,]D'8E%02I@8J:::29>J
MJ[A90J:90^\<P![:J`3@.J$T6"L+<ML2YSG7ULVFXFH^=:(+/4(ZX8Y-@K),
M$%"$4<L3HNG22ADP4*)TS"4Y0-TW!J(5+"!7LK0X%;.U:KEQK1%@C-_)[`'&
MZ)3F<WY5M+'K5<N]HUF'XJS+X@B8O=86_')/9QZB!R[142;F3*;H)@KL>WMH
M;EW7,8-O6<UT\'$M%&-_2>ZC`?87`KJ&Z]^[.V/;BYW7J-M9,</A:]U7N_1C
M:'2.%<*AI%<*J-.Y?/7P$M]\HS9R>6;K(0YR_'VQCU-=B<I=-%"'F)^&<"0_
MH&J8#](!66+3TW\DW,?F/990GP?,:CWY&/'X5@R]]7O#]I,88Y-1G`/S1VXR
M_89)(S^!9$L#S6^/F_';=DME:6L5=T8B:/Y^VA,Q2(K*;0(DHYBTYMNB(F-M
M$QS%3`0'4P!UKB]3X"Y,TQA>+..Y:`3_`",K'&@ZFCLA/N`K[%S6C>J;AK6)
M!&[4);1Q_P#402,'N)8)`/>2![5)M9M\V=D6W6%W6%<\#>-L2A#'CYZVY1G+
MQ;K8;:H1-XR561[R)O=4((@=,P;3``AI6([_`$^^TNZ=9:E#)!=LZL>TM<._
M0T-/`]#V6>-+U73-;L6:EH]Q#<V$@^&2-S7L/CBTD5'0CJ#@15>JKY%R"41*
M(E$2B)1$HB41*(E$2B)1$HB411I^23)982P+<QFS<"1]><F64E$R&$#?(H(Y
M5@*;3_)6E#(AH/02E&I8FU-3T5CCV7T>-_&/R#',_DE\VV/KXD@91"AR^\$!
M"&42%5$P]2D>2BBI3`&FOPY1^BDCJF@Z*K1W6*O);B_L/[.RW'MQ[;Q,UJ7(
MHF70I7".BT([6/KJ91=(3(%]@%2#Z:K$ZF"H\=UF?QSY,_.;%<GC]ZOODK`D
M=&13GU4/`2QE'#0$R>Q!BN!D]?I-5L@H:]E5IPHI$JC5R^.1>IQL>^D5BF,D
MP9NGJI2??,FU0.N<I/YPE3'3ZZ(HL\;\P;YS;R:LZV(Y,]I8^;NII(8%!8JS
MN:,V24(FXFW8$#N@`EU(B31,H]?6I2P-97NK0233LI6-:B5R?PT1*(E$6)<Y
M8L;9GQA<V/'#\8H\V@V.SD03%4K.08/$'[-55$#%%5`5VX%4+ZB0PZ==*N:<
MIJJ$5%%IMQ8X2W'AG(:F0+SN:,D%8U@]CX2,A4W)2JJOA3*I(/5UC^Z0B)!*
M1(`U$QA$P]`JYSP1055`VAJI(@'6H^BN4-_E=\FS/A9:;;&N,?@ICD)?D2L[
MB2N2%<Q^/K>6%1H%VRR`:E<22K@I@CFA_=5.F8Y_P9!`V=>&.))-_7IU;5\S
M-L6T@#J8.F>*'RF^#0/G=V!`&)PUD]0_/$7%NG-T+0<LF\[R(EE<6V\9J!*\
M=W$U\MIP)!<<!0QG<%/$Q>W,4K3EESNO"]I:.OU7\Y+;LYY+.D[IO.+?E!=O
M<%Q2O=!U;L/([@.V9MBIJ*(`4QMI#@%98Y&YIT[8Q=LOCJ"W;-;#(^4-'EQ.
M;@6,;2CW-Z.<:BN&)!6">(_3KJW)K6\B<NW-U);WA\R.`O(EG8X5$DKZUC8[
MJQC0"6@'`$!3EQOB\\?\9'MHTG%3$KQ-LB"/Q<G`?,9)<``0%1S(.5SNEEAU
M^^)M=?2M>)>7>2II73'6+QI<:T:_*T>P-`I3V=%MI;\"\/V\#;=N@:>YC12K
MF%SC[2XFI/M6DO*7P3<6\H6O,O\``K!QA'(Z+5RXA2Q[Q[(V1)O$T1%M&RD`
M]<*E8M%U0VF7;&(J777J`:5D'9WJ+WAHUVR'<;AJ&ED@/S`-E:"<7->!\1'8
M.J%BGD#TD;`W!82S[18[2M=#2697.="X@8-<QQ.4$]7-(/?%90\)$)<-F\-Y
MO&MVLBQ5SXLSYE>P+@C"CJ:.EX=:$</FZAM`*IJN_$Y#E]U1(Y3!T&N(]04]
MM?;[CU:R<7V=YIMO,QWYS7!X%/#!M".Q!"Y[TJ6U]IO&4VAZFT,U#3]:O+>1
MO=KV&,N!\<7$@]P00I@-?M_=_'6#JK95<U5$HBXUHB:]=*(N=:(N-:I5%QN^
MK[/KJO>B+G7^2B)K]0T.")K]5.J+FB)1$HBKS\F[MD,\\F)&(@A%\@G/1^.[
M821-N*L5H]%FNJ0`Z%46D5EMP^T"!K4[0&LQ49Q*GKL.T(^PK,MBS(HI"L;:
MA6$2B8A`("QFB!"+N3%]BCM?>H?VB8XU"34U5X%!1>'Y`8V0RQB*]+*.F4SM
M]%*NXA39O40F8X/BX]1``$-%5%$NT`_0H-5:<IKV0BH4(_#3(J^*^0%OMY-4
MS*,N9=Q95QI*'!))%=PHHBR5<F-J!21\J3</T^E3R`%M0HP:'%6'=*^92J/B
M_+[YLMY*_&L;BBTGUC@M<;:'>K2;)N]"W`%V1H\7VR!Q4<_+M#"78&IO94@#
M.M<5:<W3LHM>.$O>T'G&W96Q[8:W;=J#R5,VMMU)$BVSPZA50>)_,3$4*@*.
MHB!A`WI4KP"S'I56#JIFV62N6QTQ,]XUVNF)@(9(K;+L$([3%U,"Q7#9$R9P
M$?30?KJ&C/%2?$O0Y?RMEG'.-6U]1F+X>3=,(5:5O6-?W@U;)VT<@MB%;M%F
MR#@9LQ!5,)A2`I1`G0>O2C0"ZG9"2!5:(XP\A-PO)V[[BR>>,:V]%VYOM>SK
M?9]MY+SJSC:BU*\7,HLX,4I=3'$"$3)[!'360QCLK<Q757-RRYIR;9Q=]OXR
M<VU9ATU%F*@60_EFB:!2=WN+2SDZ)G(=L`'4$R``#[?6JAC*T*H7'MU6XUS\
MD,DV)B2V\F2.)UKGA%K/MN9N"Y&,]$QC9&3F&[4BQ"P)U%I=NW3?N`*813VE
M`P:".E6!@+LM5=4TK18NXM<J[_Y`YJFXV8:QUOVG'V@]?,+<C0%R(/`D&")'
M3V37337=K$2.8"@!4R%W#T'UHYH:W!4!)*D*N":9VW`S=Q2`B6/@8B2F7Q@$
M`$K.+9K/G(@)M"@/90'UZ5=:V\EU<QVL/\[+(UH][B`/PE0WMU%8V<M[-_,P
MQ.>[]%C2X_@"HBX68R7DJ\H<4_O=PYEX#(>4I2[I9L;=VD\6V0=:6:6^B'<`
MK)`UJ0Z;?4F@=U0YP+N,.OHSKTD/%/$#V:<!'=6MFV-I'>XFHTO/B?,<7#V`
M#H%Y&;7BGYRY^CDU8F2UO=1=*]N.%K!5_EC'X1Y+`PT[FM*E7RVS5NR;-V;-
M!%JT:((M6K5ND1%!LV;IE200013*5-)%%(H%*4H`4I0``#2O.%[GRN+Y"7/<
M223B23B23X^/BO7F.-D4;8H@&Q-```%``!0`#H`!@`OHJBO7&E4HBQC'6+"8
MPA\ERF,;/:*7#><Y.Y'DH5.0"/2NS(#N!C(HJCA\]4.VC#RR%O,FYU/=23V;
MQ#[PCRTVHW&KSVD.KSN^ZV\;(&ORYC'"'N=@&XNRYW.`ZFM%P$&D6F@6U_<Z
M!;--[=327+V!V437)C8RI<[!I>(XVDX`4KXJL9R9\UO+>*R[)<=XK%MD8+NB
MW,D-;$O&79S_`/B),%`D\U8O"P[Q1BRA6:IT1$`6(5T70PZ>P0VXVEP#LJ;1
M6[HFO+C4;.:T\Z)I9Y#<6%PS-J7G'L2W\2T,WWZI^1K?<C]DP:?:Z1J$%[Y$
M[VR?>7X2!IR.+0P$C\H!V'3Q5JFW%UG5OP3IRH99PYAHQPX6/IO5769(**J&
MV@4NY10PB.@`&HUIS<L;'<R,8*-$C@/<"5Z$6+W264,CS5[HFDGQ):"2H^_(
MSR\SCPRQD3+N.\)6MDS'\2FBWONX[AOPMM.+6DIR9BX"URQ\`V8/Y&X$74A(
M_AQ)VP2#;UT$PER9Q;L?;V_=7^AZGJ$UIJCS6&-D/F>8UC7/D+GDAK*-;AUK
MC[*X:YMY)W7Q?H0W)HVE07^C1@"XEDG\LQ/D>R.$-C#2Z0.<[XB*4P]I&E_B
M,\@&?N<68N03C+3Z#86S:5KV6O:%FVU&)LHN$/*2MQD=N%7:HJR$D^61:ID,
MJH<I1*0-"%KOG-G&FVN/=#TQNBMD==S32B261U7/RM90`"C6BI)H!7VE8N]-
MW,N\.6=S:S)N)\3-/M[:`PP1-#6,SOE!-<7.<0`"2:88`*07G9R&S_QHQ5,9
M0PYA6V,IP-IP4A/7S)7'?2-KC;;!J=-)-=A#D:NI&X5_PN\4DM@:!ZZ]*QGQ
MUM?;6[-9CT?7-0EL[F:1K(6LB,F<GLYQ(:P=JE9GY<WIO'8NWY=P;9TN#4+*
MVA=).^2<1>4T8`M90NE.-2!3!0&\4O.!DJ3RCE?)?*NZF"..[8Q<[6L/$5B0
MS.-_..\W=PQS:+81QG)G#^1F`9K'*HNJN1!)#>H8@`7ILEO/T^:5%H]GI.S8
M''4Y;P>=<S.+BR(,<7%U*-:VH%&@9B:`'%:>\>>J_6Y]>U#7.0KA@T>"P=Y%
MG`QK?,G,C`QK:U<7Y2X%SG90T%Q`HNNRQY$O,%F%HOD?$."+_P`5X?$3OH9S
M:V*I&X-8XA>Z564NJ8CE0?@H@F!C`FW2*340#4.M2:+Q=P?H<C=+UO4;:\UO
MH\27#6?$<*-C:X9<<,25%N+FKU*;FB.M[;TF\T[;7S,,5H^3X.M7ROC.;#'`
M-'@K(&(L]QS3A[C+D1G*>;VHW6PQ:-_9"FYU`(DD>\>V\Q>RHN&.W<@[5?+"
M0C8A14,J8$RE$P@%:L:YMJ1^^;O:^W8C.X7\L,#&'/4!Y#:'N*"I=6@&)P6[
MNW-XP1<96&]=VS-MXSI<-Q</D&3*YT;7/JWL2XT#1B20`*J!.\/*ESBYR96F
M<.^.C&IK>M^/!?OWM)LX]U<'RGXH6S:YIB6FQ3MNQ6+HXE%%-;O*GU`HZ&U+
M6R%EPUQ[QYHK-=Y0N_-N74I$TD,S4J8VM;_*2N'<B@[],5J%J7J$Y7Y9W!+M
MKA2Q,%DT&L[@TR9:T$KWR?R4#2>@-3B.]0NUF>#_`)Q56:=X?I;)2MUM4W*C
M>W&]\LF+GN.$A%1(%S0[6V1%0P`0-QA*41U#0.M06_(7I[;)]Q.BEMD2*O,)
M(Z]:9B_#J>Y7U77%/JL?&-2&X`_4FU(C%R&G$5I7((\3AUH/<O#<>?+QRKXK
M9K)Q_P#(I;\@_BV[QI&R]UR40UC+XM(KTI/A+D<'BT4HJ[K:7*<BAE$$R&!$
M1.F)_NUR.Y^$-F[RT#]I>+I6MF+2YD8<3%+3JP9OBBD&(H32M`0.JX;9?J3Y
M"X_W4-F\U0O=`'AKY7,#)X<WRR'(,LT1%#5H^6I!)P5I8EXVNI:`WZG.QQ[-
M"WU+J&XRN2&BPMU)@:44EQ=`(D^"3CR"J)_80!K3TV-V+WZ<8W??_-\O)3XL
M^;+EIXYL*+T!&IZ>[3?K`FC.E^3YWFU&3RPW.7UZ90W&O@O2U\J^Y81Y&9&1
MQ9AJ^;N,H0CU&'<1T,0Y]@N)F43.S8))F#T5WJ"<O^A51B50F@43GCUQLK>F
M97U^RJ1G;"PV*TB+E8N\CBZ)@3),Q.8?1TF0ZKHH_P"<GK4\AH,%8WKBM^^6
M'D#XR<,TX]IF2]C(W7,-/F,18=NLE)R[GL<*JB(2)X]$Q&\<P.LD<B:KM9`B
MIB&`@F$IM.[[+XSW=OPN?H-O6S8[*Z9[@R,._-J<7'Q#02.]*A8PY$YDV'Q@
M&1;FNB-1E;F9;Q-,DSFU(S91@UM00"\M!((%:%?-Q/\`(9Q?YEG?1F'KV4&\
M(MG\QDK"N=BI!78W8;MIGR#)8RC65:(F$`5.S6<%1$P;]NH:W;TXQW?L,-FU
MRW'W![LK9HR'QEW@2,6D]@YK:T-*J/CKFG8/)Y=!MJZ/U-C,SK>5ICF#:TS!
MIP>!W+'.#:BM%&1S3QJKBO/<R]BDA91-UF0O*`.0O;11=G53&10;@&@[&<B0
M#"/KJ?UKHT9#@LI.P=139X!R,AE?$5D7J10%'<A#HMI<!,!CDFHW_4)+N@'W
M#KN&XK`7U`B@5`X4<0I`:BJR'=?]E[E_$$S^3G-!U0]%`3PT_6BM+\87!_16
M^RIG_+16-ZJPMI_)^[VU`I%@3E"'_#]E;K_LF]_IHU<P5<![50X!0P\',?1.
M0,]V^A/,T7\3;D9(W,HU<%*H@N]CRHIQQ%D3]%DRN5]^@Z@`D`:FD-&X=58W
MJK#&@``%````#333H`:::``=-`"OG4BU>YE$(GQGR@4A"D(6)C]"$`"D`/GL
M8.@%#0/4:OC^<*UW11O^-C_?1<G]Q'GY4CJOD^7[5:WJI/.602)N,>?0B>Z,
M@.)KY^%!#_I=_P`@?;MFO37MZ_O5V#9?E?M=IHGIY7WV&M>GSA=/Y&\[]@M8
M^[U\[Z=/2G7^;<JA'@.-'?IXQ0.A2^+'%M]_*P4U[GQ`1J8N.Q_/^![FO\W6
MMX/4F)?[MWEE?+^^0YO"F8T_#1>;7I!\H<PL\VGF_<;G+[\HK3][57?0]`KS
MY7JRE$2B+\^W]\/X:H4JO\^_G/\`_P!,\V=0_63'Z`_VJ:!_&->F7'@/]TNG
MU/\`[5_X97C1RS_COJO_`-X?^]:K^EJ_V7MO\0P_Y/;UYKWG_G)?]X[]8KV+
MT[^SX/\`<L_5"BX\W8Z>.#-NOI\ZQ0'_`-J6A67_`$_?XJ:?X>7<_P##RK`'
MJM_P/U6G^VL_^+A42_[.`8/\2N3H?^CL=#]'3YM=7L$>FM9J]5/]E:1X>?-^
MK&M<?0[_`&[K_P#1;;]>93\>1@?^!OD[IT'_``JG/WO?;?96M?%A_P#T32/Z
M8S\:W%YNI_=-K_3^SI/Q*GYX;\'6SG/G+CF/O*,:35L6)'3>0G\0_10=LG[^
MWF)U8!!XT<@=!XS":,B=5(Y#E.0NA@TZUO%SMN&[V[QY=2V#G1W=PYD+7MJ"
MT//QD$4(<6U`(I1>:OIDVG8[MY:LHM4C;+I]HV2Y<QP!:YT3:QAS3@6^86D@
MC$"BOJ@&T`*````&A0`````--``/0``/XJ\WC4G%>ORJZ?M$?(^79'Q'Q>@I
M!PTC)1@ME*^DFRXD3E"%>/(6V(EZ4@E,*;-5HX="01$A^Z01#4H5M_Z7MJPR
M??=WW#6F=CA;PDCY30.D</::M;7M0^)6@7K5WQ<Q'3MA6;W-@>S[U/E.#L71
MQ,=[LKWTZ8M/8+&OBD\BO"GACQO=6AD1S<[+*UTWE-3]XOH>T7$B5TR**3>W
M&@R*:Q0518,0,!2AIH8QATZUR_,W%V_=^;K%]I8A=HT,#61-?*&D'K(<M,,S
MOP`+@O3QS;Q;QAL=VFZT;AFX+BZ?),Z.$N!:*",9JX@-KAV)/BI.1\\'`?U^
M?Y#]-/[#O?;H'_:/6L1#TY<D_P"RM?\`MA_J6>?\W?$'7S;[^KN_UJ%SS"<U
M^(7-.VL4S^&'%P+Y0L26E8R1>2]KJ0HOK,F$$W`-%WZ@G.Y)%RC85$$Q'0AG
M*@@'4:S[P;Q_OC8-U>VVO"(:/<,:X!L@?EE::5R]LS30G]R/!:N>I?E3C7E*
MQTZ[VN9SKUI(]KG/A,>:%X!REQZY'MJ!7#,ZG4K>CQ_9QELI>&#F19,T\<OG
MV$,&\C;*:/5U5CJE@I'#UUW!`LB*'#0$XMF[[*>T1VE*`=-*QUR9M^#1^>="
MU&W`;'J&H6,I`&&=MS&QYI^Z(J?:5EKAO==SKWI<W-I=TYSIM*TC4H6D]?+=
M9S21M'L:"6CV!66JU/6]2B*\F&3"G<V7BEDYT(U(>[[A(FIJ&\P*-8EHZ3_R
M3$*!ER?2!JFB'Y1Z*QQ[+;/A!C$<<8)@7#QN*,W>Z@W;*`H3:LD@](4L8T4'
MT,5%D4#E$/8K5DAJZG95;@,>JI5>59Q?+GG[R-&_OC2R:5X((0Y70*]I.T4X
MB/"U@CRG$Q/@3PPI&#MCL%43CT-N"O3#AMNG-XTTKZ:&F(P$OI3^=+G>97VY
MJ^VE/8O&;U#OU9W,6N?6,WW@70R5K3R<C?)RUPRY*=,*U[U74>,)S?37GEQO
M''IG@3:U]=AX5J*G:5MP\3(?G"G)E)[AHT(X#F."GX,#@0?O;:FY=9IS^.-5
M^I%IMQ;U%:5$F89*?NLU*4QI51<`OU9G+FB_1<WWHW0!I6GEEI\S-3#+DS5K
MA@KEOD.Q>%X8A0OAB@*DMCI^605%)(#**0#\Q&DH4Y_4J#/<5P/^A7F5$<2%
M[//JL)^-#)H@>]<2OW(;!`EWVZD8V@`IJ1E.HI@(CN45)\.J`!Z%2,-72@=0
MJ-/92G77UM>Y/Q!,?DYS40ZJX]%`/PT$/TH[1#Z7]P_Q%7J=WRJQI^*BL+U\
MZD6!>4/ZOV5O[IO?Z:-7QX/"H[HHN/&LV14S#<CDY1%9M9ARHF`Q@*4KAVF5
M74H"`&W`D7U]*DD^7[58WJIP:@4BU?YF_JT92_%,?^7(RKX_G"H[HHW/&O\`
M[Z+D_N&\_*D=5\GR_:K&]5-K(L4)*/?QSILS>-G[-RS<-'[<KIBY1<HG14;O
M6QM"N&BQ#B50@_?((A[:LBD=%*V5I+7-<""#0@@UJ#V(['Q5)XF3PO@D:UT;
MVEI#A5I!%"'#N#W'<*I*?R=37$WF0^QI>_#+B5C)IC_)Z]DW1>F.<=R]N7VQ
ML1[(%9+SL#)A/&;E6D;3=D<;3)F1.4XE$NFH!NL.(X-Z;$;JMAKVM7;[JT$L
M<4\[9(3,UM0U[<E:-E&7`U%*KSD=SQ-QSR:[0M3VOMVP%G?&&6:VM71W#;=S
MLKI(WB4@%T1S"HHX&A&*MJP\S%7#$1<]!R#26A9N.92T1*QZZ;IC)1DBV3>,
M7[)RD8R;AJ[:K%43.41`Q#`(>M:5SP36L[[:Y:YEQ&XM>T@@M<TD$$=B"""/
M%>C-K=6][;1WEF]LEI*QKV/:06N:X5:YI&!!!!!&!"[.HE.N-?JHBX^SZOW?
MP53#NBJ.<I?)(IC[FQD[%/Z&_#F[0@,T#:P7W=F-I*1OF5TGV[/YY*RR<X@D
MO.>_W!5!(`[@`.GLK=K9_%8U+C^SUGZ]KL/FZ?YGDQSAL+?@)R-;D/P=J5Z+
MS@W]SB-'Y4U#;O[,[9N##JAB\^:U<Z=]'@>8]_FBLG?-EZXT5L^!<_&0<*[[
M*+?XJ)CG/P[<NQ!#OLT5>R@01$2HI;]I0UZ%`*TLN6B.XDCJ31[A4]30G$^T
MKT7LW^;:124#<T;30=!5H-![!V6@?E(SVRXY\/[TR&YL#'F4G7YQ6/"QEB94
MAE;@LF;=R-TQO>-*Q3=XR6<*1C!%9TW$J@;'")#"`@`UDGB#;4FZ=\6^F,N;
MJS9Y4KW36[\DK`(W?*X@TS$AKL,6DK#OJ`WA#LCC6ZUF6SLM0?Y\#&P7<9E@
M>72MKG8'-)+&@O;C@YH*T3\,W,@_*&]<X11N.W'?"`6G;MG/OC\(V8]M5]/C
M)/YY`6T\JZE)$KMLQ^#W(@4"B0RANHZUD;GC8K=H6&GSC5=4U`SRRC+=S"0,
MRM9BP!K:$U^(]P`L1^F#DX;_`-5U6W;HFBZ4+:"%V:Q@,+I,[I!22KWY@*5;
MTH25+-S'OL<8<7,X9`+:UK7L-I6'*S`6G>S!24M.>^',A_5\]'I+(*.X];=J
M<A3E$=`ZUA;8FF_5]X:=IGG36XFN6M\R(Y9&5K\3'&M'#L5L7R=K'T#C_5M9
M^[V]U]VLWO\`)G:7PR4I\,C015I[BJA%\1'-UUR<Y'7%:).+?%?#:,%CB2N!
MS=.(;$D+:NU8GQ[)@E&D?.)9^D>/66=`*J8E#4`Z#6P/-_'[-I;6BO3K&LW[
MI;IK!'<S-DCZ$EU`UI#@!@:K53TW<J'?>]IM-CT#;^F,BLGR.EL[9T,QHYK0
MT.,CP6DN^(4[*RAII]>O_)6J1JMYE6F\N7-^4XR<EX2SG'$_B_EQE-XXA;AB
M[SS'84A<ET.4#OG\>Z8MY%O,,4@C6#UF8A";-0,`]:VNX3X]BW=M.2_;K6KV
M4D=T]CHK:81Q@T:02"T_$0<<5HMZC^59=B;YCTZ?;N@:C%+8QR,GO+9TLI!<
M]KFYA(WX&N:0!3K5;X^/:-XP\S.,EIYKG>+O&Z$NE](S4%=<+:^,;<"'C)N%
M=`BLDT1DVLA(H)*(J$.4%53B.NH"(5CODZ7=^P]VS;?M]8U62T:QCXW27#\S
MFO%<2TAIQKT`67>&K78')^Q+?=-WM_0XK]\CXY616D08U[#3`/#G`$$'%Q]Z
MW<_0^XI#_P#F[!__`,86=_Y16/AOG>?;5=0_K$O\994_NRXZZ_0M)_JL'\1!
MX?<4?7]&[!_3_P!L+.Z?3_X13]N=Y_\`RNH?UB7^,@XSX[&'T/2:?T6'^(O?
M6SA/#UF6W<MG6CBZP+9M.\D'3:[;:@;2A(J"N5N^CSQ+U"=BF3)%G*(NXM0S
M=0JQ#@=$1(.I1TKC+O<&N7]U%?7MY<S7L!!CD?*]SXR'9@6.)):0[XA0BAQZ
MKF;#:NV=+L9],TW3[.#3KD$311PQLCE#FY'"1C6AKP6DM.8&HPZ+)+EP@S;K
MNW2J;=LU15<N%U3`5)!!`AE5EE##T*1-,HB(^P`KB5SZKSJ#)<I^60@`JK,;
MDO/8`F`R@,+,M]UIM,4-P_#)L4-FOT*U]&#6J+$N]BL*LV;>/9M6#-(J#1BV
M0:-4"!H1%NV2(B@D4/85-,@`'V5\YJ?>I5HOR]\<7&/FFO&366;8?,KVAF@,
M(Z^[1?C!W(,>10ZB4=)N$DSI3#!`RR@IIKE-VS'U*(:!61=C\I[NV"Q]MHDS
M3I\CLQAD;G97N6]VDT%2#C18BY)X2V'RB]EUN&W<S58VY6W$)R2916C7&A#V
MBIH'#`G`K^'$/QM\8N%SR0G\5VU(25[RS0&#V^KP?A.7`BQ$PF58Q"JB*:,*
MS=#M%8B!2BJ)0W"/I4F^.5MW[^C;:ZQ*UFGL=F$,0R,+OSG8DN([$]*X*SC;
M@[87%TC[S;T#WZK(W*Z>9V>0-[AF`#`<*AHQIB5N_<4$PN>"F+>E4$G4=-QK
MR,>H+$!1-1N\1.B<#$'H8`WZZ?2%8V"S!V5=2RY&5XS\E(\TB9=#\QKU5B)C
M4#`H[METJ9@Z7%,-N\SZ!=]T@#T`QP^BOH^8>Q1="K%<DB6<MZ009JIG)+PS
MM)HL4P&2,609*$04*8HB4R8@J`Z^@A4`P*DZA5]>*T@QM+E-:Q;@<DC"IW+.
MPQU7@@@FD^66=-T4USJF(5`AU"::F$``1"IW?)7LHV_-7M13ZW-?UFV>W;.+
MDN.)BROG+=FP2</$0<OW;M0$FK9DV*<5W*JZI@*7:40U'J(5``2I*A8TY0_J
M_96]1TM-Z/3KT`Z-59\P1W11?>-,0_Q:NL-0U&S2:!KU'1[UT#U$`UJ63Y58
MWJINZ@4BU?YF_JT92Z@']51W41T#K.Q8!U^L1J^/YPJ.Z*-GQL*)ES7<28G*
M"AK"?F*37WC%3E(ON&*'M`F\-?M"KY/E^U6-ZJ<:H5(H!_,AXQY;DG&!R-P7
M%I.<Q6?!G9WA:#9$A'.2+9CRJ+MU8XQ2ZKW;"I[RH$,/^M(&%/7>!*V3X(Y<
MM]IRG:NXGENASR5CE)J('NP(=_T;^Y_)./2JT[]3O`USOJW&]]I1AVYK6*DT
M(%#<Q-Q!;XRL&`'Y;?AZ@*)WQ]>7_)7#!FWP+GBUI^^<26TX5C8U@H51CD/&
M9S.CG<1C5&5,E\9"MU5SG%BL!5$`+M1$`-I6:.2^#])W[(=Q[<FCMM<E%7.'
MQ0SX"CCEK1Y``SMP=U=T6NO#7J4U[BZ-NT-WV\UWMR$EK&_+<6OQ&K6YZ5C!
M))C=0MZ-(K16-+%\NGCYOF'2EPY$6M9XJID4&*OU-Y;$REO$P"15DX16*"B8
ME]X`.;34!ZA6K6I<)\F:=.83I<TX!^:$B1O^D'\2W?T?U&\.ZS;"Y9K$-M4?
M).'1O'O!!'X5BK-OFXX*XGCGI[9OE_F><20$\?$XW8'=L'SC:!BH.+B?_"QT
M>0=1#N'`X;NF@US&W_3]R'K4K?O=NVPMB<73NH0/8QM7./LP77MU^JCB?;D+
M_N-U)J=Z&U:RV;5KCX&1V5K??C[EZSQP\GN4?+YYE7-.6L<-L5X+?A!1."[;
M,U70E9$6JTB>X+@>.GQ"/Y5)V@=J4%]I6W<`X(@)0U'XN5-H[/V0RST#1+HW
MFXV9W7;Z@M;4-R,`'PMH<U14NH078K[^$=^<@<DS:CNG<=DW3]I/\MEA%E(<
MZA>9)"YWQ/!&3XJ!N;,&8"IK,>9/%]PX:\@M^W0JQ60B<@J6WE*T9$$CMT)/
MNHMOFW86`-@KQ]QL%T5!`=VI0,(:"%;:\$:M:Z_QI;637`S6PDMY&UQ:03EK
MX!T9!'OHM#O4[H%YM?F6\U`M<VVO'1W<3Z4#LP;GH?%LC7@^X'NK86%>?O$6
M[L(67?1L^XZB6;>SX$)]K<%R,(N9A)-K$M4I)A*QCI8KU-XU<I'*8`(;=IJ`
MB`A6F&X.--[V6X;C3AIMT^0SOR%D9<US2XY2UPPH1[5Z)[5YDXWU+:=IJ[M8
MLHHQ:Q^8))6L?&X,`<U[2<P<""#@JY7E[YV!S1C"6I@%E,R_&O",\RD+VR.H
MR<,H:ZLAS)UX6WFT>HIH56/9LEW!VQ3:'<@H=7:4J9:VFX.XZ_8*7[[N1S&;
MJU",MB@J"Z.!M'O+OW1(`=V%`VN)6DGJ6Y9/*%N-.V>R638^DS-=/<%I:R6X
M>3'&!7\D-+BP'%P)?0`!9I_9NV[4]]<J7)W9$W;>V,5HMV`]%'2#B2O<SIT4
M/\QF=!(IOK6+7`>JM[_IVC,#:QF6XJ[P(;%0?:"?]!79_0Y&PZMN&5S@)1;V
M@#>Y!?<5/V4`_?*?;R%,U9#A+R99H'0355Q3<&T[E8K=`O;*BJ;>L?W":E(.
MFOJ/2M;.,)!'R!I+W5H+QG3'Q'1;A\TQ.FXHUZ-I&8Z=)B3084.)59C]GA52
M+RXR0F90A5%L*O@2(8P`9027'#',!"B.IA*0HB.GH`5MGZGFD[*M'#H+\?J/
M6B7HM(;R/?`D5.FR4]O\I$5<P]:T0]R]/5"/YMN$DQR6P5$Y9QS#FE<I8-+)
M2*D8R;"O)W1C]TF+B<B6I4R'<.GD,X2^,;(EZ"!U_4P@%;!>GW?\&TMQ/T35
M9,FCZB6M#G'X8Y@:,<:X`.!RN/:C>U5JIZJN*KG?6T8]QZ+'YFOZ2'N+6BKY
M;<BKV"@J7,<,[6CJ"_N0J^?C!\DTOP,O6X+<O&%E+IPG?3Q`]VP#$>W.6I/M
M=C4ET0K9P8B:KA%L44G;0VT52![H@H`#6S'+O%$'(^GQW5A(R'7[=I\IY^21
MAQ\MQ&-"<6O['K@M-.`^<KKB'59K#58GS[8NWCS8VX21R##S6`T!(%0]I^8=
M*$!6P\?^4G@9D.%;349R.L.#,X1*LI"7>^&V[@8@.GNOHM^0JB)_>TT`Q@UU
MK3'4N'N1],N'6\NE7,N4_/$/,8?<YO5>B6C\_P#$.LVC;N'6[2$N%<DQ,4@_
M2:[I]E5@KD1YJ.%>&8!^>R+Y2SG>@H*IPUM8Y*9^P6D]0310EI]4J3*.0!0P
M"82]PY@#:0!,-=AVQP'OW7[EHU&W.G:?7XY)\"&]:M8,7>';VX+J>]?5'Q?M
M>S<=*NOJVJ%I\N.VQ:7=*/D-&M'<TJ:=,5F7#/(_/T]X^+QY1Y)L)I'9=:XI
MS!EFV<>(Q3]FW6;6]!7#<>/X`\>`#+K?,FL>V3,(A\2MW==-P@%<)KVU-M6W
M)T&SM)N'.T0WMK;23%S2:O>QDS\WRC*7./YHIX+LVU][[QO.&;K?^N6C8]R-
MT^\NXK<,<`1&R22W9E^<Y@UHZ9S7I59?YJY,#&V!;G,V<_#S5W@6SXC8<`5`
MTJFJ,BL!/OBD2,25(8P?=,J7TU"L8Q@EP6:''!:@>-'&`F7O+++]#4J)2VA;
MRBI!W`8>VZF7;=00$#%-JFB;KZE$/LOE(&`5&>*ERJ%7I1$HB410\>13!<JC
M/M,V0#)1U#R#-I$7>5HB8YXU^S`R<;+NM@&-\*]0,5`Z@Z%3,D0!^\%31N_)
M[JQP[K(G#?F1;CJW8;%64I=*&G8=)*+MFXY$Q$(R6C$2$181SYZH?8VE&I0!
M,IE-"K%`O7=J%6O9W"!W8K*F7^"&+\N7&[O>!N.3LF7FG'Q\HO!H,Y2*D'9A
M`YGZ#159`C9RJ?WC'34$IAZ@`4$A`H<0JY0OSCK@58]IW-$79>5\WADV3MYV
MW>P2,\L+:/9+M52*H"HV%W('7(F<@"!043+J`:@/I0R&E!@$#<5G7..%97-4
M4%N'R7<5FVPX;?#S$+`L&*A)P>\"Q1?O'!P<@@42%_!$$I1V^\(@.E6M=E[8
MJI%5KE8W`5EC2?1N>QLTWO;TVB@LU!XSBXDW=:N``JS9=!911!9$^T.AB]!#
M4-!JXOKA14RK?R.;N6C!FV>/#2+I!LBBX?G1(W.\63(!3N3H)F,FD=8P;A*4
M=`$1TJ-7+7C.O'V3SD0T5(95NBV;/6;-$G=H0T?&J1L@Y:.#.2/7SE<2O%U.
MYL$";@3*)`'01JYKLN-,50BJP-9/`!ACB?0NBQ\T7O;D\W24;DD6,5$BH=JL
M)!7:.$UE%47#9QVPWD,70=`]!`!J[S*]1@J95(*U251;-T5UQ=+)())K.3$*
MF9PJ0A2*KF3((E(*QP$VT.@".E1JY?VT_=K3J$6B7)[QN<1N6BRLME'&;5C>
M*_0]_P!CJIVK>*NICJ'%](-&ZK24.H<WO*.VZZH@``!P*&E9%VCRKO;9;1!I
M%V76`Z0RUDB'N!-6_O2![%B3?G!_''(KC<:]8M9J1I6X@(BF.-?B<`6O]I>U
MQIA6F"C1=?LZ7'!25^)9YJRNTB-3:Q2C*`=.-!W;?ZT$$3`)0$.O9ZZ5EEGJ
MCW4V`QOL+,S?G!SP/X./_.L$2^B?9#KGS(]5U!MK^9DB)_A4'ZJV]P/X8.#6
M#91I<)[%E<JW&R.W<-7V4Y5.X(]F];&WE=,H%LT81@;C>I'!')/JKI&Y.>N1
M-Q0NM6W#+*U=4$6[<CB#U!>27?:TM62]H^E_B?:=PV\-I)J%XVA!NG![&N&-
M6QM:UGV.#@I5VC-JP:MV3%L@S9,T$6K1FT23;M6K5NF5)!NV;HE(B@@BF0"D
M(4"E*4```T"L-/>^1YDD)=(XDDDU))Q)).)-?'JMA(XXX8VPPM#(FM`#0```
M,``!@`!T`Z+6;E%PZP)S#L]O9^<+.)-IQIEE;?N.-<?*[KMAPX+L67@YHB:R
MC<5"AH=-0BJ)AZB01T$.V[/WSN38U\;[;\^3/3/&X9HY`.F=M17V$$$>*Z)O
M_C/9_)>FC3=UVPE#*^7(TY9HB>IC?0TKW!!:?"JB9:_L[7%9.XDY!WE++CRW
M2'*8UO=Z"0=G("N\4QGBLCJ@!D@V"((:^VLTO]4&\'6OE,LK%MU3Y_C(_@5I
MU]OL6NT?HMV`V]\Y^H:DZQKC%_)@G_K,OA^Y]JW?R[XN^/E^\66W$ZP$G&&;
M#0NB$NUS*6NP:RD[,S,*50OQTXZDE4SRCUZ"@[U5#^YJ($*4O2L?:)S!N?3=
MXG>FI$7^HF)T8;(XM8UCJ8,`^4"F`'VDE93W+P!LS6>/V\=Z.':7I(N&3.?$
MUKY)'LK\4A<1G<[N2<.P`P6L7'KPKL^+F1(C).&.767;5F&C^*-.,4;:MY2(
MNVWV4FU?R%L3S$9`$G$?*HH&1%33NH`H)DQ`==>W[GY]=O#2I-)U[0[*:%S7
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M4HE,`"&3-?\`4+/NC3G:3KNB6-Q8.():Z204(Q!!`!!![C[5AK:WI.M]E:LS
M7-L;EU*TU2,%H>V&$U:X4<US22"",#4>T4(4YD&SD(Z&BF$K*&G)-E&LFDC-
M':I,3R[UNV31<R1V2)U$6BCY8@J&3(82D$V@#H%:[W#XY9WR0L\N%SR6LK7*
M":AM3B:#"IZK;2TBF@M8X;F3SKAC&ASZ!N=P`!=E%0,QQH,!5=H(:_7]7TU$
MOH46/)WP]\-^3,V^O%[:LGB^^Y$RJ\A<>,G+6#;2[U8X&.^G(!1HO%OG`]=3
M)%;&,(ZF$PZZYBVASEOO:5NVQ9,R\TYH`#+@%Y:!V8\$.`]A+AX+7[?OIIXQ
MWW<OU*2W?8:L\DNDMBU@>X]7/C+2PGVC*3U)6BX_LX^#!5W?I"9-[6\3%2&V
MK=$2D$VH$[@O/4"]-=/KTK(G^:;<-*?2[3-3J)']?&E%B/\`R1;3S5^M7^2O
M3RHJT]]?Q+=GC=X:N%_'2X(^\D[7F,J7C%F37CI3)SQI-Q<8]2$!(]C;<29-
MXQ-<!UT[X.0*(Z@`"`"&/]U\[[]W3:NL#,RSL7U#FP`L<X'LYY)=3]'+[5E;
M9'IBXOV5>,U-MO)J&IQD%KKHM>QKA^4V(-#*_I9E*UVDNUV.TGV>WVNSL+VN
MUMV=KMZ;.WLZ::::=*PUF=FS8YJUK_R[K8;*W+DH,E*4[4]RU$Y=\;IWD3!V
M<TM^Y&<$^M23E')D),C@T>_;R[=DBH=0S8%%"N60L0%+W!`04-U#VW,=D-51
MPJLUX6Q;&X;QO;>/XU8'80[43/WX)`A\RE71A7D7XI`)MGQ+DPB`"(B`:5:X
MYC55`H%E2J*J41*(E$7R/6+.39.HZ1:MW[!\W5:O&3M%-PU=-ER&360<(*E,
MFLBJF82F*8!`0'TJH)!J.J*/7*OCHQK=SUQ+X_FGN/'C@3JJQ)6WSJWC+&U.
M/PS=PY0>L`54'KM54(4.A2%#I4C92.M%86`^Q8IA.'_,*Q"C&V%G.+8PA`$B
M#52Y;H:MDD]>@(Q1H>39-1$`#44Q`:N\R,FI;BF5R]G&8#YV-U-S[.T$N34/
M<+<4X;Z-==;5)3S(OS4H[Q638G$7+)N!?F&6HEP(::[9F5-KIZ]!M\FM"^/\
MU*.\5[^/QWR"1V_&9"CU=/7;)/S:C]AH@M65C\%6CE[)I9^74]/B;O9J>FNC
MQUU]?IC@JE8_`JF4KTC:W<@D`._<+=3V"'Q*XZ_PLZI5O@KJ'Q7=H0]V%T[L
MLD?Z?PZH_P#=@&J88IBNS2CIXOWY`@_8JH/377VI!0JJ^TK25#U=%'Z?PAO^
MKH*=U3'N5]1$7P#[RP"&OKN-T#Z-`+5#3LB^@J:X:ZJ`/[XC_P`VBJOT!%?:
M<-/M'^2B+^]$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41
H*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB__V3\_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
